Evaluation of soluble HLA-G as a biomarker for multiple sclerosis

Neurology. 2011 Aug 9;77(6):596-8. doi: 10.1212/WNL.0b013e318228c14d. Epub 2011 Jul 27.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Cohort Studies
  • Disease Progression
  • Enzyme-Linked Immunosorbent Assay
  • HLA Antigens / blood*
  • HLA-G Antigens
  • Histocompatibility Antigens Class I / blood*
  • Humans
  • Interferon beta-1b
  • Interferon-beta / therapeutic use
  • Longitudinal Studies
  • Multiple Sclerosis / blood*
  • Regression Analysis

Substances

  • Biomarkers
  • HLA Antigens
  • HLA-G Antigens
  • Histocompatibility Antigens Class I
  • Interferon beta-1b
  • Interferon-beta